Literature DB >> 11245653

Regulation of cardiomyocyte mechanotransduction by the cardiac cycle.

K Yamamoto1, Q N Dang, Y Maeda, H Huang, R A Kelly, R T Lee.   

Abstract

BACKGROUND: Overloading the left ventricle in systole (pressure overload) is associated with a distinct morphological response compared with overload in diastole (volume overload). METHODS AND
RESULTS: We designed a novel computer-controlled experimental system that interfaces biaxially uniform strain with electrical pacing, so that cellular deformation can be imposed during a specified phase of the cardiac cycle. Cardiomyocytes were exposed to strain (4%) during either the first third (systolic phase) or last third (diastolic phase) of the cardiac cycle. Strain imposed during the systolic phase selectively activated p44/42 mitogen-activated protein kinase (MAPK) and MAPK/extracellular signal-regulated protein kinase kinase (MEK1/2, an activator of p44/42 MAPK) compared with strain imposed during the diastolic phase. In contrast, there was no difference in activation of p38 and c-Jun NH(2)-terminal kinases induced by strain imposed during the systolic phase (5.8- and 3.3-fold versus control, n=4) compared with the diastolic phase (5.5- and 3.1-fold). Induction of both brain natriuretic peptide (5.8-fold versus control, P:<0.05, n=3) and tenascin-C (7.0-fold, P:<0.02) mRNA expression by strain imposed during the systolic phase was greater than during the diastolic phase (3.9- and 3.6-fold, respectively). [(3)H]leucine incorporation induced by strain imposed during the systolic phase (4.0-fold versus control) was greater than during the diastolic phase (2.7-fold, P:<0.02, n=4); a selective inhibitor of MEK1/2 inhibited this difference.
CONCLUSIONS: Mechanical activation of p44/42 MAPK and MEK1/2, gene expression, and protein synthesis is regulated by the cardiac cycle, suggesting that mechanotransduction at the cellular level may underlie differences between pressure and volume overload of the heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245653     DOI: 10.1161/01.cir.103.10.1459

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status.

Authors:  Young Wook Chun; David E Voyles; Rutwik Rath; Lucas H Hofmeister; Timothy C Boire; Henry Wilcox; Jae Han Lee; Leon M Bellan; Charles C Hong; Hak-Joon Sung
Journal:  J Biomech       Date:  2015-10-08       Impact factor: 2.712

Review 2.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

3.  New insights into the molecular phenotype of eccentric hypertrophy.

Authors:  Sebastiano Sciarretta; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2010-04-08       Impact factor: 5.000

4.  Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.

Authors:  Yuchuan Liu; A Ray Dillon; Michael Tillson; Catherine Makarewich; Vincent Nguyen; Louis Dell'Italia; Abdel Karim Sabri; Victor Rizzo; Emily J Tsai
Journal:  J Mol Cell Cardiol       Date:  2013-04-06       Impact factor: 5.000

Review 5.  Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Renjun Zhu; Adriana Blazeski; Ellen Poon; Kevin D Costa; Leslie Tung; Kenneth R Boheler
Journal:  Stem Cell Res Ther       Date:  2014-10-20       Impact factor: 6.832

Review 6.  Mechanical regulation of gene expression in cardiac myocytes and fibroblasts.

Authors:  Jeffrey J Saucerman; Philip M Tan; Kyle S Buchholz; Andrew D McCulloch; Jeffrey H Omens
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.